SUMMARY OF COMMON STOCK WARRANT ACTIVITY (Details) - Common Stock Warrant [Member] - $ / shares |
3 Months Ended | 12 Months Ended |
---|---|---|
May 31, 2025 |
Feb. 28, 2025 |
|
Class of Stock [Line Items] | ||
Number of Series F Preferred Warrants, Outstanding Beginning balance | 41,271,449 | |
Weighted Average Exercise Price, Oustanding Beginng balance | $ 0.003 | |
Weighted Average Remaining Years, Outstanding | 2 years 2 months 4 days | 2 years 5 months 8 days |
Number of Series F Preferred Warrants, Issued | ||
Weighted Average Exercise Price, Issued | ||
Number of Series F Preferred Warrants, Exercised | ||
Weighted Average Exercise Price, Exercised | ||
Number of Series F Preferred Warrants, Forfeited and cancelled | ||
Weighted Average Exercise Price,Forfieted and cancelled | ||
Number of Series F Preferred Warrants, Outstanding Ending balance | 47,271,449 | 41,271,449 |
Weighted Average Exercise Price, Oustanding ending balance | $ 0.001 | $ 0.003 |
X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises in period Weighted Average Exercise price. No definition available.
|
X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments forfeitures and expiration Weighted Average Exercise price. No definition available.
|
X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments grants in period Weighted Average Exercise price. No definition available.
|
X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise price. No definition available.
|
X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average remaining contractual term. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|